Around 1.8 million Europeans died of cancer last year, making it the second-biggest killer after cardiovascular disease. In November, Horizon looks at powerful new techniques that could improve cancer survival rates.
We look at technology that allows doctors to stay ahead of mutations in tumour cells by adapting treatments in real time, and we examine techniques that can turn a patient’s immune system against cancer.
For our Views section, Professor Martine Piccart, a former president of the European Organisation for Research and Treatment of Cancer, explains what is required to individualise cancer therapy, so that it matches the specific needs of each patient.
Thousands of young people are being interviewed as the EU backs the largest study in the world into the links between mobile phone use and brain cancer in children.
Professor Martine Piccart is a past president of the European Organisation for Research and Treatment of Cancer, Chair of the Breast International Group (BIG) and head of medicine at the Jules Bordet cancer hospital in Brussels. She explains that cancer research needs to change so that cancer treatment can become truly personalised.
Cancer treatments could change radically over the next decade, thanks to technology that can monitor cancer cell mutations in real time.
Medical researchers are using genetic engineering to revolutionise the treatment of cancer.
A new wave of personalised vaccines could harness the power of patients’ own immune systems to fight an aggressive form of brain cancer.